Literature DB >> 14716736

Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells.

Gero Kramer1, Georg E Steiner, Marion Gröbl, Kristian Hrachowitz, Franz Reithmayr, Ljubomir Paucz, Martin Newman, Stephan Madersbacher, Diego Gruber, Martin Susani, Michael Marberger.   

Abstract

BACKGROUND: To investigate the possibilities offered by high intensity focused ultrasound (HIFU) in the field of tumor vaccination, we analyzed how prostatic cancer (CaP) cells react towards heat treatment and whether increased access to CaP cells by the immune system would be the result.
METHODS: Heat/stress response of CaP cells in situ and of CaP cell lines was analyzed by immunohistochemistry, Western blotting, and Atlas array. A heat-induced change in immune recognition was analyzed functionally using human T-helper (Th)1 and Th2-cytokine release with tumor infiltrating T-lymphocytes (TIL) as responder and autologous CaP cells either heated or untreated as stimulator cells.
RESULTS: Transcription of 68 out of 500 genes was upregulated by sublethal heat in LNCaP and PC3 cells. Significantly upregulated stress protein (SP) expression (HSP-72, -73, GRP-75, -78) was seen at the border zone of HIFU treatment. Remarkably, even untreated benign prostatic hyperplasia (BPH) specimens revealed relative overexpression of heat shock protein (HSP)-72, -73 and glucose regulated protein (GRP)-75, -78. Heated CaP cells increased Th1-cytokine (IL-2, IFN-gamma, TNF-alpha) release but decreased Th2-cytokine (IL-4, -5, -10) release of TIL.
CONCLUSIONS: HIFU treatment may alter the presentation of prostate tissue and tumor antigens and this presentation is most likely stimulatory. HSP-72/73 overexpression in untreated BPH may suggest a mechanism by which BPH can incite inflammation. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14716736     DOI: 10.1002/pros.10314

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  22 in total

1.  High intensity focused ultrasound-induced gene activation in solid tumors.

Authors:  Yunbo Liu; Takashi Kon; Chuanyuan Li; Pei Zhong
Journal:  J Acoust Soc Am       Date:  2006-07       Impact factor: 1.840

Review 2.  Focused Ultrasound for Immunomodulation of the Tumor Microenvironment.

Authors:  Jordan B Joiner; Yuliya Pylayeva-Gupta; Paul A Dayton
Journal:  J Immunol       Date:  2020-11-01       Impact factor: 5.422

3.  High intensity focused ultrasound-induced gene activation in sublethally injured tumor cells in vitro.

Authors:  Yunbo Liu; Takashi Kon; Chuanyuan Li; Pei Zhong
Journal:  J Acoust Soc Am       Date:  2005-11       Impact factor: 1.840

Review 4.  Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment.

Authors:  Christopher Bastianpillai; Neophytos Petrides; Taimur Shah; Stephanie Guillaumier; Hashim U Ahmed; Manit Arya
Journal:  Tumour Biol       Date:  2015-09-30

5.  Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound.

Authors:  Ying Zhang; Jian Deng; Jun Feng; Feng Wu
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

6.  Current and Future Clinical Applications of High-Intensity Focused Ultrasound (HIFU) for Pancreatic Cancer.

Authors:  Hyun Joo Jang; Jae-Young Lee; Don-Haeng Lee; Won-Hong Kim; Joo Ha Hwang
Journal:  Gut Liver       Date:  2010-09-10       Impact factor: 4.519

7.  Evaluation of pulsed high intensity focused ultrasound exposures on metastasis in a murine model.

Authors:  Hilary Hancock; Matthew R Dreher; Nigel Crawford; Claire B Pollock; Jennifer Shih; Bradford J Wood; Kent Hunter; Victor Frenkel
Journal:  Clin Exp Metastasis       Date:  2009-06-11       Impact factor: 5.150

Review 8.  Ultrasound mediated delivery of drugs and genes to solid tumors.

Authors:  Victor Frenkel
Journal:  Adv Drug Deliv Rev       Date:  2008-04-03       Impact factor: 15.470

Review 9.  Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy.

Authors:  Ezekiel Maloney; Tanya Khokhlova; Venu G Pillarisetty; George R Schade; Elizabeth A Repasky; Yak-Nam Wang; Lorenzo Giuliani; Matteo Primavera; Joo Ha Hwang
Journal:  Int Rev Immunol       Date:  2017-09-29       Impact factor: 5.311

10.  Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation.

Authors:  Fang Liu; Zhenlin Hu; Lei Qiu; Chun Hui; Chao Li; Pei Zhong; Junping Zhang
Journal:  J Transl Med       Date:  2010-01-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.